GERALD W. CRABTREE

Corporate Board Profile

Tech Score: 0/100

← Back to All Directors

PharmaCyte Biotech, Inc.

Filing Date Source Excerpt
2023-06-05 Gerald W. Crabtree (7) 15,600 * Includes 4,000 shares issuable upon the exercise of options to purchase common stock and 11,600 shares upon the vesting of restricted stock units. Mr. Crabtree resigned from all positions with the Company effective October 12, 2022.
2023-07-31 Gerald W. Crabtree - Director, includes 4,000 shares issuable upon the exercise of options to purchase common stock and 11,600 shares upon the vesting of restricted stock units.

Source material: SEC submissions metadata and DEF 14A proxy filings from EDGAR. Last updated: 2026-03-22